Clinical validation of the Tempus xO assay.

Nike Beaubier,Robert Tell,Robert Huether,Martin Bontrager,Stephen Bush,Jerod Parsons,Kaanan Shah, Tim Baker, Gene Selkov,Tim Taxter,Amber Thomas, Sam Bettis,Aly Khan,Denise Lau, Christina Lee,Matthew Barber,Marcin Cieslik,Casey Frankenberger, Amy Franzen, Ali Weiner,Gary Palmer,Robert Lonigro,Dan Robinson,Yi-Mi Wu,Xuhong Cao,Eric Lefkofsky,Arul Chinnaiyan,Kevin P White

Oncotarget（2018）

引用 38|浏览46

暂无评分

摘要

We have developed a clinically validated NGS assay that includes tumor, germline and RNA sequencing. We apply this assay to clinical specimens and cell lines, and we demonstrate a clinical sensitivity of 98.4% and positive predictive value of 100% for the clinically actionable variants measured by the assay. We also demonstrate highly accurate copy number measurements and gene rearrangement identification.

查看译文

关键词

Tempus,cancer,gene panel,genomic test,transcriptome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要